Methylphenidate (Ritalin®) management of complex regional pain syndrome type I (reflex sympathetic dystrophy) due to an electrical burn

Pain Digest

Volumn 7, Issue 5, 1997, Pages 266-271

  Mellick, Gary A ^a  

^a American Pain Specialists Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE; BUPIVACAINE; FENTANYL; GABAPENTIN; METHYLPHENIDATE;

ADULT; ANALGESIA; ARTICLE; CASE REPORT; ELECTRIC BURN; EPIDURAL DRUG ADMINISTRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PAIN; SYMPATHETIC DYSTROPHY;

EID: 0030722333     PISSN: 09389016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Raj P: Tutorial 26: Complex regional pain syndromes (reflex sympathetic dystrophy and causalgia). Pain Digest 1996;6:298-316
2. Ritalin HCL package insert. Summit, NJ, CIBA Pharmaceutical Company, Rev. 2/92
3. Johnstone M: The effects of methylphenidate on postoperative pain and vasoconstriction. Brit J Anaesth 1974;46:778-783
4. Bruera E, Brennesis C, Paterson AH et al: Narcotics plus methylphenidate (Ritalin®) for advanced cancer pain. Amer J Nurs 1988; 88:1555-1556
5. Bruera E, Brennesis C, Paterson AH et al: Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage 1989;4:3-6
6. Bruera E, Fainsinger R, MacEachern T et al: The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report. Pain 1992;50:75-77
7. Yee JD, Berde CB: Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer. J Pain Symptom Manage 1994;9:122-125
8. Wilwerding MB, Loprinzi CL, Mailliard JA et al: A randomized cross-over evaluation of methylphenidate in cancer patients receiving strong narcotics. Support-Care-Cancer 1995;3:145-148
9. Vigano A, Watanabe S, Bruera E: Methylphenidate for the management of somatization in terminal cancer patients. J Pain Symptom Manage 1995;10:167-170
10. Cantello R, Aguggia M, Gilli M et al: Analgesic action of methylphenidate on Parkinsonian sensory symptoms: Mechanisms and pathophysiological implications. Arch Neurol 1988;45:973-976
11. Mellick GA: An open clinical trial using methylphenidate (Ritalin®) in the management of pain of sympathetic origin. In Proceedings of the 8th World Congress on Pain. Seattle, WA, IASP Press, 1996
12. Reflex sympathetic dystrophy (RSD): A case report. (Product monograph.) Minneapolis, MN, Medoc Ltd. Advanced Medical Systems, 1995
13. Ochoa JL, Yarnitksy D: The triple cold syndrome: Cold hyperalgesia, cold hypoaesthesia and cold skin in peripheral nerve disease. Brain 1994;117:185-197
14. Price DD, Long S, Huitt C: Sensory testing of pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy. Pain 1992;49:163-173
15. Longmire DR, Stanton-Hicks M, Raineri T et al: Laboratory methods used in the diagnosis of sudomotor dysfunction and complex regional pain syndrome: A critical review. Pain Digest 1996;6:21-29
16. Longmire DR, Woodley WE: Selective tissue conductance meter, K874850A, Office of Device Evaluation, Food and Drug Administration, U.S. Dept. of Health and Human Services, 1988
17. Kuczenski R: Biochemical actions of amphetamine and other stimulants. In Creese I (ed): Stimulants: Neurochemical, Behavioral and Clinical Perspectives. New York, Raven Press, 1983, pp 31-61
18. Geyer MA, Dawsey WJ, Mandell AJ: Differential effects of caffeine, D-amphetamine and methylphenidate on individual raphe cell fluorescence: A microspectrofluorimetric demonstration. Brain Res 1975;85: 135-139
19. Fields HL, Basbaum AI: Brain stem control of spinal pain transmission neurons. Ann Rev Physiol 1978;193-221
20. Yaksh TL: Direct evidence that spinal serotonin and noradrenalin terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res 1979;160:180-185
21. Porrino LJ, Lucignani G, Dow-Edwards D et al: Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res 1984;307:311-320
22. Dill RE, Costa E: Behavioural dissociation of the enkephalinergic systems of nucleus accumbens and nucleus caudatus. Neuropharmacology 1977;16:323-326
23. Jin WQ, Zhou ZF, Han JS: Electroacupuncture and morphine analgesia potentiated by bestatin and thiorphan administered to the nucleus accumbens of the rabbit. Brain Res 1986;380:327-334
24. Yu LC, Han JS: The neural pathway from nucleus accumbens to amygdala in morphine analgesia of the rabbit. Sheng Li Msueh Pao 1990; 42:277-283
25. Atweh SF, Kuhar MJ: Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon. Brain Res 1997;134:393-405
26. Stein EA, Miller JM, Simon EJ: Effects of stress on opioid receptor binding in the rat central nervous system. Neuroscience 1992;51:683-690
27. Hong JS, Yang H-YT, Fratta W et al: Determination of methionine enkephalin in discrete regions of rat brain. Brain Res 1977;134:383-386
28. Ma QP, Han JS: Neurochemical studies on the mesolimbic circuitry of antinociception. Brain Res 1991;566:95-102
29. Ma QP, Shi YS, Han JS: Naloxone blocks opioid peptide release in N. accumbens and amygdala elicited by morphine injected into periaqueductal gray. Brain Res 1992b;28:351-354
30. Han JS, Xuan YT: A mesolimbic neuronal loop of analgesia: I. Activation by morphine of a serotonergic pathway from periaqueductal gray to nucleus accumbens. Int J Neurosci 1986;29:109-117
31. Xuan YT, Shi YS, Zhou ZF et al: Studies on mesolimbic loop of antinociception. II. A serotonin-enkephalin interaction in the nucleus accumbens. Neuroscience 1986;19:403-409
32. Ma QP, Shi YS, Han JS: Further studies on interactions between periaqueductal gray, nucleus accumbens and habenula in antinociception. Brain Res 1992a;583:292-295
33. Burstein R, Cliffer KD, Giesler GJ Jr: Direct somatosensory projections from the spinal cord to the hypothalamus and telencephalon. J Neurosci 1987;7:4159-4164
34. Burstein R, Giesler GJ Jr: Retrograde labeling of neurons in spinal cord that project directly to nucleus accumbens or the septal nuclei in the rat. Brain Res 1989;497:149-154
35. Cliffer KD, Burstein R, Giesler GJ Jr: Distributions of spinothalamic, spinohypothalamic, and spinotelencephalic fibers revealed by antero-grade transport of PHS-L in rats. J Neurosci 1991;11:852-868
36. Gear RW, Jon D, Levine J: Antinociception produced by an ascending spino-supraspinal pathway. J Neurosci 1995;15:3154-3201
37. Yarnitsky D, Sprecher E, Zaslansky R et al: Heat pain thresholds, normative data and repeatability. Pain 1995;60:329-332
38. Yarnitsky D, Fowler CJ: Quantitative sensory testing. Clinical Neurophysiology. London, Butterworth, 1995, pp 253-270
39. Navarro X, Kennedy WR: Evaluation of thermal and pain sensitivity in type I diabetic patients. J Neurol Neurosurg Psychiatr 1991;54:60-64